# Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients

Study · id `cardio:ct-nct01186107` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01186107](<https://clinicaltrials.gov/study/NCT01186107>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01186107

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 256 participants.

## Technical summary

Registry record NCT01186107. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2012-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 256 participants (enrolled count; ClinicalTrials.gov record NCT01186107, source copy `cardio:ctgov-nct01186107-2014-07-29`, retrieved 2026-10-26)
- Start date: 2010-08 (registry gives no type) (ClinicalTrials.gov record NCT01186107, source copy `cardio:ctgov-nct01186107-2014-07-29`, retrieved 2026-10-26)
- Primary completion: 2012-12 (actual) (ClinicalTrials.gov record NCT01186107, source copy `cardio:ctgov-nct01186107-2014-07-29`, retrieved 2026-10-26)
- Completion: 2013-07 (actual) (ClinicalTrials.gov record NCT01186107, source copy `cardio:ctgov-nct01186107-2014-07-29`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01186107, source copy `cardio:ctgov-nct01186107-2014-07-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01186107-2014-07-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
- Acronym: ESSENCE-DM2
- Condition: Coronary Artery Disease
- Condition: Diabetes
- Intervention (Device): Endeavor Resolute stent
- Intervention (Device): Cypher stent
- Lead sponsor: Seung-Jung Park
- Lead sponsor class: OTHER
- Collaborator: CardioVascular Research Foundation, Korea
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Seung-Jung Park (`cardio:org-seung-jung-park`)
- Registry lists this organization as a collaborator: CardioVascular Research Foundation, Korea (`cardio:org-cardiovascular-research-foundation-korea`)

## Provenance

Content hash: 920cbb524e2e478b5d49c80bb299793ce29f77a483749fc2ca77df8843c23b7a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
